Search Results - "FROHMAN, E. M"

Evidence-based guideline: Clinical evaluation and treatment of transverse myelitis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology by SCOTT, T. F, FROHMAN, E. M, DE SEZE, J, GRONSETH, G. S, WEINSHENKER, B. G

“…To assess the evidence for diagnostic tests and therapies for transverse myelitis (TM) and make evidence-based recommendations. A review of the published…”
Get full text

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis by ZIVADINOV, R, REDER, A. T, FILIPPI, M, MINAGAR, A, STÜVE, O, LASSMANN, H, RACKE, M. K, DWYER, M. G, FROHMAN, E. M, KHAN, O

“…Disease-modifying agents (DMAs), including interferon beta (IFNbeta) and glatiramer acetate (GA), are the mainstays of long-term treatment of multiple…”
Get full text

Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis by GORDON-LIPKIN, E, CHODKOWSKI, B, REICH, D. S, SMITH, S. A, PULICKEN, M, BALCER, L. J, FROHMAN, E. M, CUTTER, G, CALABRESI, P. A

“…Optical coherence tomography (OCT) noninvasively quantifies retinal nerve fiber layer (RNFL) thickness. Studies show RNFL thinning in multiple sclerosis (MS),…”
Get full text

Disease modifying therapies in multiple sclerosis: Report of the therapeutics and technology assessment subcommittee of the American Academy of neurology and the ms council for clinical practice guidelines by GOODIN, D. S, FROHMAN, E. M, GARMANY, G. P, HALPER, J, LIKOSKY, W. H, LUBLIN, F. D, SILBERBERG, D. H, STUART, W. H, VAN DEN NOORT, S

Get full text

Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact: An evidence : Report report of the therapeutics and technology assessment subcommittee of the american academy of neurology by GOODIN, D. S, FROHMAN, E. M, HURWITZ, B, O'CONNOR, P. W, OGER, J. J, REDER, A. T, STEVENS, J. C

“…The clinical and radiologic impact of developing neutralizing antibodies (NAbs) to interferon beta (IFNbeta) while on this therapy for multiple sclerosis (MS)…”
Get full text

Quantitative sensory testing: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology by SHY, M. E, FROHMAN, E. M, SO, Y. T, AREZZO, J. C, CORNBLATH, D. R, GIULIANI, M. J, KINCAID, J. C, OCHOA, J. L, PARRY, G. J, WEIMER, L. H

“…This assessment evaluates the clinical utility, efficacy, and safety of quantitative sensory testing (QST). By searching MEDLINE, Current Contents, and their…”
Get full text

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy by STÜVE, O, CRAVENS, P. D, MACMANUS, D, MILLER, D. H, RADÜ, E. W, CAMERON, E. M, MONSON, N. L, ZHANG, S, KIM, R, HEMMER, B, FROHMAN, E. M, PHILLIPS, J. T, REMINGTON, G. M, VON GELDERN, G, CEPOK, S, SINGH, M. P, COHEN TERVAERT, J. W, DE BAETS, M

“…Natalizumab is a humanized recombinant monoclonal antibody against very late activation antigen-4 approved for the treatment of patients with multiple…”
Get full text

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology by GOODIN, D. S, ARNASON, B. G, COYLE, P. K, FROHMAN, E. M, PATY, D. W

“…Mitoxantrone is the first drug approved for the treatment of secondary progressive multiple sclerosis (SPMS) in the United States. This assessment considers…”
Get full text

Pearls & Oy-sters: The medial longitudinal fasciculus in ocular motor physiology by Frohman, T C, Galetta, S, Fox, R, Solomon, D, Straumann, D, Filippi, M, Zee, D, Frohman, E M

“…To review the role played by the medial longitudinal fasciculus (MLF) in ocular motor physiology and to characterize a number of syndromes that result from…”
Get full text

The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology by FROHMAN, E. M, GOODIN, D. S, KACHUCK, N. J, LEVIN, M. C, PHILLIPS, J. T, RACKE, M. K, RIVERA, V. M, STUART, W. H, CALABRESI, P. A, CORBOY, J. R, COYLE, P. K, FILIPPI, M, FRANK, J. A, GALETTA, S. L, GROSSMAN, R. I, HAWKER, K

“…Advancements in imaging technologies and newly evolving treatments offer the promise of more effective management strategies for MS. Until recently,…”
Get full text

Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis by DAVIS, S. L, FROHMAN, T. C, CRANDALL, C. G, BROWN, M. J, MILLS, D. A, KRAMER, P. D, STÜVE, O, FROHMAN, E. M

“…The goal of this investigation was to demonstrate that internuclear ophthalmoparesis (INO) can be utilized to model the effects of body temperature-induced…”
Get full text

Multiple sclerosis and the urologist by Litwiller, S E, Frohman, E M, Zimmern, P E

“…We provide an updated reference detailing the neurological and urological state of the art approach to multiple sclerosis (MS) with special emphasis on the…”
Get more information

Retinal architecture predicts pupillary reflex metrics in MS by Salter, AR, Conger, A, Frohman, TC, Zivadinov, R, Eggenberger, E, Calabresi, P, Cutter, G, Balcer, L, Frohman, EM

“…Objective To study the relation of retinal nerve fiber layer thinning to clinical and physiologic measures of visual function in patients with MS or…”
Get full text

MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis by FROHMAN, E. M, ZHANG, H, KRAMER, P. D, FLECKENSTEIN, J, HAWKER, K, RACKE, M. K, FROHMAN, T. C

“…The authors imaged the medial longitudinal fasciculus (MLF) in 58 patients with MS and chronic internuclear ophthalmoparesis (INO) to determine which MRI…”
Get full text

Cup to disc ratio by optical coherence tomography is abnormal in multiple sclerosis by Syc, S.B, Warner, C.V, Saidha, S, Farrell, S.K, Conger, A, Bisker, E.R, Wilson, J, Frohman, T.C, Frohman, E.M, Balcer, L.J, Calabresi, P.A

“…Abstract Objective To identify and characterize cup to disc ratio (CDR) and related optic nerve head abnormalities in multiple sclerosis (MS) using spectral…”
Get full text

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis by Devonshire, V., Lapierre, Y., Macdonell, R., Ramo-Tello, C., Patti, F., Fontoura, P., Suchet, L., Hyde, R., Balla, I., Frohman, E. M., Kieseier, B. C.

“…Background:  Most disease‐modifying therapies (DMTs) for multiple sclerosis (MS) are self‐injectable medications that must be taken on an ongoing basis to…”
Get full text

Extended interval dosing of natalizumab in multiple sclerosis by Zhovtis Ryerson, L, Frohman, T C, Foley, J, Kister, I, Weinstock-Guttman, B, Tornatore, C, Pandey, K, Donnelly, S, Pawate, S, Bomprezzi, R, Smith, D, Kolb, C, Qureshi, S, Okuda, D, Kalina, J, Rimler, Z, Green, R, Monson, N, Hoyt, T, Bradshaw, M, Fallon, J, Chamot, E, Bucello, M, Beh, S, Cutter, G, Major, E, Herbert, J, Frohman, E M

“…BackgroundNatalizumab (NTZ), a monoclonal antibody to human α4β1/β7 integrin, is an effective therapy for multiple sclerosis (MS), albeit associated with…”
Get full text

Accuracy of clinical detection of INO in MS: Corroboration with quantitative infrared oculography by FROHMAN, T. C, FROHMAN, E. M, ZEE, D, CORBETT, J, CORBOY, J, RIVERA, V. M, KRAMER, P. D, O'SUILLEABHAIN, P, SALTER, A, DEWEY, R. B, HOGAN, N, GALETTA, S, LEE, A. G, STRAUMANN, D, NOSEWORTHY, J

“…The authors compared the accuracy of clinical detection (by 279 physician observers) of internuclear ophthalmoparesis (INO) with that of quantitative infrared…”
Get full text

BREAK IN BINOCULAR FUSION DURING HEAD TURNING IN MS PATIENTS WITH INO by MILLS, D. A, FROHMAN, T. C, FROHMAN, E. M, DAVIS, S. L, SALTER, A. R, MCCLURE, S, BEATTY, I, SHAH, A, GALETTA, S, EGGENBERGER, E, ZEE, D. S

Get full text

Benign paroxysmal positioning vertigo in multiple sclerosis: diagnosis, pathophysiology and therapeutic techniques by Frohman, E M, Kramer, P D, Dewey, R B, Kramer, L, Frohman, T C

“…Objective: To report on the most common causes of vertigo in patients with multiple sclerosis (MS) and emphasize appro priate diagnostic techniques and…”
Get full text